Chemfab Alka.

  • Market Cap: Micro Cap
  • Industry: Commodity Chemicals
  • ISIN: INE783X01023
  • NSEID: CHEMFAB
  • BSEID: 541269
INR
378.00
-1.7 (-0.45%)
BSENSE

Aug 14, 04:01 PM

BSE+NSE Vol: 1.83 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

1.83 k (-57.59%) Volume

Shareholding (Jun 2026)

FII

0.04%

Held by 2 FIIs

DII

0.14%

Held by 0 DIIs

Promoter

72.13%

Why is Chemfab Alkalis Ltd falling/rising?

15-Aug-2026

As of 14-Aug, Chemfab Alkalis Ltd's stock price is at 378.00, down 0.45%. The decline is driven by significant long-term underperformance, reduced investor participation, and the stock's position below key moving averages, indicating a bearish trend.

As of 14-Aug, Chemfab Alkalis Ltd's stock price is currently at 378.00, reflecting a decrease of 1.7, or 0.45%. This decline can be attributed to several factors highlighted in the data. <BR><BR>Firstly, the stock has shown a significant drop over the past year, with a decrease of 44.72%, compared to a modest decline of 3.21% in the benchmark Sensex. This long-term underperformance may contribute to negative investor sentiment. Additionally, the year-to-date performance shows a decline of 8.36%, which is slightly better than the Sensex's decline of 8.46%, indicating that the stock is not significantly outperforming the market.<BR><BR>Moreover, today's trading activity indicates a falling investor participation, with a delivery volume of 15 on 13 August, which has decreased by 88.79% compared to the 5-day average. This sharp drop in trading volume suggests a lack of interest from investors, which can further pressure the stock price downward. <BR><BR>While the stock is performing inline with its sector today and is above the 5-day and 20-day moving averages, it remains below the longer-term moving averages (50-day, 100-day, and 200-day). This positioning may signal a bearish trend, as it indicates that the stock is not gaining enough momentum to surpass these longer-term averages.<BR><BR>In summary, the combination of poor long-term performance, declining investor participation, and the stock's position relative to moving averages are contributing to the current decline in Chemfab Alkalis Ltd's stock price.

View full answer

Who are in the management team of Chemfab Alka.?

14-Aug-2026

The management team of Chemfab Alka includes Chairman Suresh Krishnamurthi Rao, along with six independent directors and three non-executive directors, ensuring a diverse governance structure.

The management team of Chemfab Alka includes the following members:<BR><BR>1. **Suresh Krishnamurthi Rao** - Chairman (Non-Executive) & Director (Non-Independent)<BR>2. **C S Ramesh** - Non-Executive & Non-Independent Director<BR>3. **R Mahendran** - Non-Executive & Non-Independent Director<BR>4. **Sujatha Jayarajan** - Independent Director<BR>5. **Drushti Desai** - Independent Director<BR>6. **A Janakiraman** - Independent Director<BR>7. **T Ramabadran** - Independent Director<BR>8. **Nitin S Cowlagi** - Non-Executive & Non-Independent Director<BR><BR>This team comprises a mix of executive and independent directors, contributing to the governance and strategic direction of the company.

View full answer

What does Chemfab Alka. do?

14-Aug-2026

Chemfab Alkalis Ltd is a micro-cap manufacturer of caustic soda, liquid chlorine, and hydrogen gas, incorporated in 2009 and formerly known as Teamec Chlorates Limited. As of June 2026, it reported net sales of 73 Cr and a net profit of 6 Cr.

Overview:<BR>Chemfab Alkalis Ltd is a manufacturer of caustic soda lye, flakes, liquid chlorine, hydrogen gas, PVCO pipes, and other products in the commodity chemicals industry, categorized as a micro-cap company.<BR><BR>History:<BR>Chemfab Alkalis Ltd was incorporated on May 6, 2009, and was formerly known as Teamec Chlorates Limited. The company changed its name on July 21, 2017, following a scheme of amalgamation dated March 30, 2017. The latest quarterly results reported net sales and net profit for June 2026.<BR><BR>Financial Snapshot:<BR>- Net Sales: 73 Cr (Quarterly Results - Jun 2026)<BR>- Net Profit: 6 Cr (Quarterly Results - Jun 2026)<BR>- Market Cap: INR 532 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>- P/E: N/A<BR>- Industry P/E: 44<BR>- Dividend Yield: 0.33%<BR>- Debt Equity: 0.30<BR>- Return on Equity: -0.91%<BR>- Price to Book: 1.41<BR><BR>Contact Details:<BR>Address: Team House, GST Salai Vandalur Chennai Tamil Nadu : 600048<BR>Tel: 91-44-22750323/24<BR>Email: chemfabalkalis@drraholdings.com<BR>Website: http://www.chemfabalkalis.com

View full answer

Who are the peers of the Chemfab Alka.?

14-Aug-2026

Chemfab Alka's peers include Tuticorin Alkali, Kanoria Chem., Transpek Inds., and others. Chemfab Alka has below-average growth and a 1-year return of -44.81%, while Kanoria Chem. leads with an 83.39% return.

Peers: The peers of Chemfab Alka. are Tuticorin Alkali, Kanoria Chem., Transpek Inds., Primo Chemicals, Blue Pearl Agri, POCL Enterprises, Lords Chloro, Mangalam Organic, and Andhra Petrochem.<BR><BR>Quality Snapshot: Excellent management risk is observed at Tuticorin Alkali, Transpek Inds., and Chemfab Alka., while Average management risk is found at Kanoria Chem., Primo Chemicals, Blue Pearl Agri, POCL Enterprises, Lords Chloro, Mangalam Organic, and Andhra Petrochem. Below Average management risk is noted at Kanoria Chem. and National Perox. Growth is Excellent at POCL Enterprises, Good at Tuticorin Alkali and Lords Chloro, while Average growth is seen at Blue Pearl Agri, and Below Average growth is found at Kanoria Chem., Transpek Inds., Primo Chemicals, Mangalam Organic, and Andhra Petrochem. Chemfab Alka. has Below Average growth. Capital Structure is Excellent at Tuticorin Alkali and Chemfab Alka., Good at Blue Pearl Agri and Andhra Petrochem, Average at Primo Chemicals and Lords Chloro, and Below Average at Kanoria Chem., POCL Enterprises, Transpek Inds., Mangalam Organic, and National Perox.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Kanoria Chem. at 83.39%, while the lowest is Blue Pearl Agri at -90.73%. Chemfab Alka.'s 1-year return of -44.81% is significantly lower than Kanoria Chem.'s and higher than Blue Pearl Agri's. Additionally, the six-month return is negative for Blue Pearl Agri, Chemfab Alka., POCL Enterprises, Lords Chloro, Mangalam Organic, and Andhra Petrochem.

View full answer

How big is Chemfab Alka.?

14-Aug-2026

As of 14th August, Chemfab Alkalis Ltd has a market capitalization of 549.00 Cr and reported net sales of 292.64 Cr with a net loss of 0.25 Cr over the latest four quarters. Shareholder's funds were 379.99 Cr, and total assets were valued at 498.84 Cr as of March 2025.

As of 14th August, Chemfab Alkalis Ltd has a market capitalization of 549.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest four quarters, Chemfab Alkalis Ltd reported net sales of 292.64 Cr. However, the net profit for the same period was a loss of 0.25 Cr.<BR><BR>The latest annual period for the balance sheet is March 2025, where the shareholder's funds amounted to 379.99 Cr, and total assets were valued at 498.84 Cr.

View full answer

Should I buy, sell or hold Chemfab Alkalis Ltd?

12-Aug-2026

Are Chemfab Alkalis Ltd latest results good or bad?

30-Jul-2026

Chemfab Alkalis Ltd's latest results show a significant profit increase due to a one-time tax credit, but revenue declined both quarter-on-quarter and year-on-year, indicating ongoing operational challenges. Investors should be cautious due to the mixed signals between profitability and sales performance.

Chemfab Alkalis Ltd's latest results present a mixed picture. On one hand, the company reported a significant increase in net profit for Q1 FY27, reaching ₹5.73 crore, which is a remarkable 1,093.75% increase quarter-on-quarter and a 124.71% increase year-on-year. This surge in profitability is largely attributed to a one-time tax credit, which significantly impacted the bottom line.<BR><BR>However, the revenue side tells a different story. Net sales for the same quarter were ₹73.16 crore, reflecting a decline of 2.17% from the previous quarter and a substantial 20.08% drop compared to the same quarter last year. This marks the third consecutive quarter of year-on-year revenue contraction, indicating ongoing challenges in the company's core operations.<BR><BR>While operating margins improved to 13.85%, this improvement comes after a period of very low margins, and the overall financial health is concerning. The company's reliance on non-operating income for profitability raises questions about the sustainability of these results. Additionally, the return on capital employed is negative, suggesting that the company is not generating adequate returns on its investments.<BR><BR>In summary, while Chemfab Alkalis has shown impressive profit growth, the underlying issues with revenue decline and operational efficiency present significant challenges. Investors should approach the company's results with caution, considering the mixed signals from profitability and sales performance.

View full answer

How has been the historical performance of Chemfab Alka.?

31-Oct-2025

Chemfab Alka's historical performance shows increasing net sales and total assets, but declining profitability, with a profit after tax of -INR 6.94 crore in March 2025, following a peak in March 2023. Total expenditures rose significantly, impacting operating profit and leading to negative profit before tax in 2025.

Answer:<BR>The historical performance of Chemfab Alka shows a fluctuating trend in key financial metrics over the years.<BR><BR>Breakdown:<BR>Chemfab Alka's net sales have seen a gradual increase from INR 204.52 crore in March 2020 to INR 334.37 crore in March 2025, with a slight dip in March 2023. Total operating income followed a similar pattern, reaching INR 334.37 crore in March 2025. However, the total expenditure has also risen significantly, from INR 149.48 crore in March 2020 to INR 290.65 crore in March 2025. This led to a decline in operating profit, which peaked at INR 115.99 crore in March 2023 but fell to INR 50.84 crore in March 2025. The profit before tax turned negative in March 2025 at INR -0.31 crore, following a positive trend in previous years. Consequently, the profit after tax also dropped to INR -6.94 crore in March 2025, contrasting with INR 64.58 crore in March 2023. The company's total assets increased from INR 296.50 crore in March 2020 to INR 498.84 crore in March 2025, while total liabilities also rose from INR 296.50 crore to INR 498.84 crore during the same period. Cash flow from operating activities improved to INR 39 crore in March 2025, although cash flow from investing activities remained negative at INR -85 crore. Overall, Chemfab Alka's financial performance reflects both growth in sales and assets, but challenges in profitability and increasing costs.

View full answer

Is Chemfab Alka. technically bullish or bearish?

04-Aug-2025

As of August 1, 2025, Chemfab Alka's trend has shifted to a moderate bearish stance, indicated by bearish MACD and Bollinger Bands, despite mixed signals from the KST.

As of 1 August 2025, the technical trend for Chemfab Alka has changed from mildly bearish to bearish. The current stance is bearish with a moderate strength. Key indicators driving this assessment include a bearish MACD on the weekly chart, bearish signals from Bollinger Bands on both weekly and monthly time frames, and a bearish moving average on the daily chart. The KST shows a mildly bullish signal on the weekly but is mildly bearish monthly, indicating mixed signals in the short term. Overall, the prevailing bearish sentiment is supported by the recent price action, with the stock down significantly year-to-date and over the past month.

View full answer

When is the next results date for Chemfab Alka.?

28-Jul-2025

Chemfab Alka is scheduled to declare its results on July 31, 2025.

Chemfab Alka is scheduled to declare its results on 31 July 2025.

View full answer

Who are the top shareholders of the Chemfab Alka.?

17-Jul-2025

The top shareholder of Chemfab Alka is Dr Rao Holdings Pte Ltd, with a 47.07% stake. V. M. Srinivasan is the largest individual shareholder at 1.81%, while individual investors hold 21.53% of the shares.

The top shareholders of Chemfab Alka include Dr Rao Holdings Pte Ltd, which holds the largest stake at 47.07%. The company is primarily owned by its promoters, with no pledged promoter holdings reported. In terms of public shareholders, V. M. Srinivasan is the highest individual shareholder, owning 1.81%. Additionally, individual investors collectively hold 21.53% of the shares, while mutual funds and foreign institutional investors hold minor stakes of 0.07% and 0.03%, respectively.

View full answer

Is Chemfab Alka. overvalued or undervalued?

09-Jun-2025

As of May 23, 2024, Chemfab Alkalis Ltd. is considered very expensive and overvalued, with a PE ratio of 367.03 and significant underperformance against the Sensex, indicating a lack of growth expectations and high valuation compared to industry benchmarks.

As of 23 May 2024, the valuation grade for Chemfab Alkalis Ltd. has moved from expensive to very expensive, indicating a significant increase in perceived overvaluation. The company is currently considered overvalued. Key ratios highlight this concern, with a PE ratio of 367.03, an EV to EBIT of 155.27, and a Price to Book Value of 2.85, all of which are substantially higher than typical industry benchmarks.<BR><BR>In comparison to peers, Chemfab Alkalis Ltd. stands out with a PE ratio significantly above the average, while its EV to EBITDA ratio of 26.21 aligns with its high valuation. Notably, the company has a PEG ratio of 0.00, suggesting no growth expectations are priced in, which further emphasizes its overvaluation. Recent performance shows that Chemfab has underperformed against the Sensex, with a year-to-date return of -26.8% compared to the Sensex's 5.56%, reinforcing the notion that the stock may be overvalued in the current market context.

View full answer

Has Chemfab Alka. declared dividend?

06-Jun-2025

Yes, Chemfab Alkalis Ltd has declared a 12% dividend, amounting to ₹1.2 per share, with an ex-date of September 13, 2024. Despite recent fluctuations, the company has shown strong long-term total returns, particularly over the 3 to 5 year periods.

Chemfab Alkalis Ltd has declared a 12% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 12%<BR>- Amount per share: 1.2<BR>- Ex-date: 13 Sep 24<BR><BR>Dividend Yield: 0.16%.<BR><BR>Total Returns by Period:<BR>In the 6 months period, the price return was -31.68%, with a dividend return of 0%, resulting in a total return of -31.68%.<BR><BR>For the 1 year period, the price return was 33.47%, the dividend return was 0.19%, leading to a total return of 33.66%.<BR><BR>Over the 2 years period, the price return was 130.2%, with a dividend return of 0.74%, culminating in a total return of 130.94%.<BR><BR>In the 3 years period, the price return was 354.78%, the dividend return was 2.32%, resulting in a total return of 357.1%.<BR><BR>For the 4 years period, the price return was 413.05%, with a dividend return of 2.46%, leading to a total return of 415.51%.<BR><BR>In the 5 years period, the price return was 440.62%, with a dividend return of 3.57%, resulting in a total return of 444.19%.<BR><BR>Overall, Chemfab Alkalis Ltd has declared a dividend, and while the recent returns show significant fluctuations, the long-term performance indicates a strong upward trend in total returns, particularly over the 3 to 5 year periods.

View full answer
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Poor long term growth as Operating profit has grown by an annual rate -201.97% of over the last 5 years

 
2

Flat results in Jun 26

3

Risky - Negative Operating Profits

4

Despite the size of the company, domestic mutual funds hold only 0.25% of the company

5

Below par performance in long term as well as near term

stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Commodity Chemicals

stock-summary
Market cap

INR 549 Cr (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

44

stock-summary
Dividend Yield

0.32%

stock-summary
Debt Equity

0.30

stock-summary
Return on Equity

-0.91%

stock-summary
Price to Book

1.45

Revenue and Profits:
Net Sales:
73 Cr
(Quarterly Results - Jun 2026)
Net Profit:
6 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.32%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-10.38%
0%
-10.38%
6 Months
-5.18%
0%
-5.18%
1 Year
-44.72%
0.18%
-44.54%
2 Years
-56.48%
0.26%
-56.22%
3 Years
16.36%
0.65%
17.01%
4 Years
56.68%
1.34%
58.02%
5 Years
135.51%
3.07%
138.58%

Latest dividend: 1.2 per share ex-dividend date: Sep-04-2025

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

Announcements stock-summary

Announcement under Regulation 30 (LODR)-Newspaper Publication

05-Aug-2026 | Source : BSE

Submission of copy of newspaper publication wrt. SEBI circular dated 30th Jan 2026 on special window for transfer and dematerialisation of physical securities.

Announcement under Regulation 30 (LODR)-Newspaper Publication

31-Jul-2026 | Source : BSE

Submission of Newspaper Clippings of Un-Audited Financial Results for the quarter ended 30th June 2026 approved vide board meeting held on 29th July 2026.

Investor Presentation For Quarter Ended 30Th June 2026

30-Jul-2026 | Source : BSE

Submission of Investor Presentation for the quarter ended 30th June 2026

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Chemfab Alkalis Ltd has declared 12% dividend, ex-date: 04 Sep 25

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
9.32%
EBIT Growth (5y)
-201.97%
EBIT to Interest (avg)
28.54
Debt to EBITDA (avg)
1.27
Net Debt to Equity (avg)
0.30
Sales to Capital Employed (avg)
0.79
Tax Ratio
91.39%
Dividend Payout Ratio
-25.87%
Pledged Shares
0
Institutional Holding
0.17%
ROCE (avg)
10.51%
ROE (avg)
7.16%

Valuation key factors

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
44
Price to Book Value
1.45
EV to EBIT
-174.12
EV to EBITDA
25.13
EV to Capital Employed
1.34
EV to Sales
2.24
PEG Ratio
NA
Dividend Yield
0.32%
ROCE (Latest)
-0.25%
ROE (Latest)
-0.91%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
Bullish
Bullish
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Jun 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 2 Schemes (0.07%)

FIIs

Held by 2 FIIs (0.04%)

Promoter with highest holding

Dr Rao Holdings Pte Ltd (47.04%)

Highest Public shareholder

V. M. Srinivasan (1.8%)

Individual Investors Holdings

21.7%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is -2.17% vs 9.74% in Mar 2026",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is 1,093.75% vs 110.79% in Mar 2026",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'26",
        "Mar'26",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "73.16",
          "val2": "74.78",
          "chgp": "-2.17%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "10.13",
          "val2": "8.52",
          "chgp": "18.90%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2.21",
          "val2": "2.14",
          "chgp": "3.27%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "5.73",
          "val2": "0.48",
          "chgp": "1,093.75%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "13.85%",
          "val2": "11.39%",
          "chgp": "2.46%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2025 is 6.10% vs -0.14% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2025 is 50.00% vs -97.39% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "168.10",
          "val2": "158.43",
          "chgp": "6.10%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "16.76",
          "val2": "18.48",
          "chgp": "-9.31%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "3.51",
          "val2": "2.16",
          "chgp": "62.50%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "0.54",
          "val2": "0.36",
          "chgp": "50.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "9.97%",
          "val2": "11.66%",
          "chgp": "-1.69%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is -2.40% vs -1.20% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is -274.55% vs -89.29% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "236.24",
          "val2": "242.05",
          "chgp": "-2.40%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "18.70",
          "val2": "30.39",
          "chgp": "-38.47%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "5.54",
          "val2": "3.36",
          "chgp": "64.88%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-3.91",
          "val2": "2.24",
          "chgp": "-274.55%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "7.92%",
          "val2": "12.56%",
          "chgp": "-4.64%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is -6.98% vs 2.16% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is 50.58% vs -126.37% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "311.02",
          "val2": "334.37",
          "chgp": "-6.98%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "27.22",
          "val2": "43.72",
          "chgp": "-37.74%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "7.69",
          "val2": "4.93",
          "chgp": "55.98%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-9.89",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-3.43",
          "val2": "-6.94",
          "chgp": "50.58%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "8.75%",
          "val2": "13.08%",
          "chgp": "-4.33%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQstock-summary

Jun'26
Mar'26
Change(%)
Net Sales
73.16
74.78
-2.17%
Operating Profit (PBDIT) excl Other Income
10.13
8.52
18.90%
Interest
2.21
2.14
3.27%
Exceptional Items
0.00
0.00
Consolidate Net Profit
5.73
0.48
1,093.75%
Operating Profit Margin (Excl OI)
13.85%
11.39%
2.46%
Values in Rs Cr.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2026 is -2.17% vs 9.74% in Mar 2026

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2026 is 1,093.75% vs 110.79% in Mar 2026

Half Yearly Results Snapshot (Consolidated) - Sep'25stock-summary

Sep'25
Sep'24
Change(%)
Net Sales
168.10
158.43
6.10%
Operating Profit (PBDIT) excl Other Income
16.76
18.48
-9.31%
Interest
3.51
2.16
62.50%
Exceptional Items
0.00
0.00
Consolidate Net Profit
0.54
0.36
50.00%
Operating Profit Margin (Excl OI)
9.97%
11.66%
-1.69%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2025 is 6.10% vs -0.14% in Sep 2024

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2025 is 50.00% vs -97.39% in Sep 2024

Nine Monthly Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
236.24
242.05
-2.40%
Operating Profit (PBDIT) excl Other Income
18.70
30.39
-38.47%
Interest
5.54
3.36
64.88%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-3.91
2.24
-274.55%
Operating Profit Margin (Excl OI)
7.92%
12.56%
-4.64%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2025 is -2.40% vs -1.20% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2025 is -274.55% vs -89.29% in Dec 2024

Annual Results Snapshot (Consolidated) - Mar'26stock-summary

Mar'26
Mar'25
Change(%)
Net Sales
311.02
334.37
-6.98%
Operating Profit (PBDIT) excl Other Income
27.22
43.72
-37.74%
Interest
7.69
4.93
55.98%
Exceptional Items
0.00
-9.89
100.00%
Consolidate Net Profit
-3.43
-6.94
50.58%
Operating Profit Margin (Excl OI)
8.75%
13.08%
-4.33%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2026 is -6.98% vs 2.16% in Mar 2025

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2026 is 50.58% vs -126.37% in Mar 2025

stock-summaryCompany CV
About Chemfab Alkalis Ltd stock-summary
stock-summary
Chemfab Alkalis Ltd
Micro Cap
Commodity Chemicals
Chemfab Alkalis Limited, formerly known as Teamec Chlorates Limited was incorporated on 06 May, 2009. The name of the Company was changed from Teamec Chlorates Limited to Chemfab Alkalis Limited on July 21, 2017, vide Revised Certi?cate of Incorporation issued by the Registrar of Companies pursuant to the Scheme of Amalgamation dated 30 March 2017. The Company is a manufacturer of caustic soda lye, ?akes, liquid chlorine, hydrogen gas, PVCO Pipes and other products.
Company Coordinates stock-summary
Company Details
Team House, GST Salai Vandalur Chennai Tamil Nadu : 600048
stock-summary
Tel: 91-44-22750323/24
stock-summary
chemfabalkalis@drraholdings.com
Registrar Details
Cameo Corporate Services Ltd , Subramanian Buildings No 1 , Club House Road, Chennai